FDA 483 - BroadMaster Biotech Corp. - April 13, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
BroadMaster Biotech Corp., a medical device manufacturer in Taoyuan City, Taiwan, was inspected by the FDA. The inspection revealed significant deficiencies in their quality system, including inadequate complaint handling procedures and a lack of implemented Medical Device Reporting (MDR) procedures. Additionally, personnel demonstrated unfamiliarity with USFDA regulations for exporting medical devices to the US market, indicating a general lack of compliance with critical regulatory requirements.
ID · ea397a3b-27c7-43f7-b9ed-5bf33f250ec2